Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis

Frontiers in Microbiology

Volumn 6, Issue JUL, 2015, Pages

  Li, Ming ^a,b   Liang, Pin ^a   Li, Zhenzhen ^a   Wang, Ying ^a   Zhang, Guobin ^a   Gao, Hongwei ^a   Wen, Shu ^a,b   Tang, Li ^a,b  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Liaoning Province Key Laboratory of Polymer Science and Engineering   (China)

Author keywords

Bacterial consortia transplantation; Fecal microbiota transplantation; Intestinal dysbiosis; Intestinal microbiota; Mucosal barrier function

Indexed keywords

CYTOKINE; DEFENSIN; IMMUNOGLOBULIN A; MUCIN 2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CONSORTIUM TRANSPLANTATION; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; HISTOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; INTESTINE MUCOSAL BARRIER FUNCTION; MALE; MEDICAL PROCEDURES; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS;

EID: 84938903548     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00692     Document Type: Article

References (59)

1. Aguilera, M., Cerdà-Cuéllar, M., and Martínez, V. (2015). Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. Gut Microbes 6, 10-23. doi: 10.4161/19490976.2014.990790
2. Ahn, D. H., Crawley, S. C., Hokari, R., Kata, S., Yang, S. C., Li, J. D., et al. (2005). TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation. Cell. Physiol. Biochem. 15, 29-40. doi: 10.1159/000083636
3. Al-Sadi, R., Ye, D., Dokladny, K., and Ma, T. Y. (2008). Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J. Immunol. 180, 5653-5661. doi: 10.4049/jimmunol.180.8.5653
4. Angelberger, S., Reinisch, W., Makristathis, A., Lichtenberger, C., Dejaco, C., Papay, P., et al. (2013). Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am. J. Gastroenterol. 108, 1620-1630. doi: 10.1038/ajg.2013.257
5. Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., et al. (2011). Treating Clostridium difficile infection with fecal microbiota transplantation. Clin. Gastroenterol. Hepatol. 9, 1044-1049. doi: 10.1016/j.cgh.2011.08.014
6. Becker, S., Oelschlaeger, T. A., Wullaert, A., Vlantis, K., Parsparakis, M., Wehkamp, J., et al. (2013). Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo. PLoS ONE 8:e55620. doi: 10.1371/journal.pone.0055620
7. Bennet, J. D., and Brinkman, M. (1989). Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1, 164. doi: 10.1016/S0140-6736(89)91183-5
8. Bennett, K. M., Walker, S. L., and Lo, D. D. (2014). Epithelial microvilli establish an electrostatic barrier to microbial adhesion. Infect. Immun. 82, 2860-2871. doi: 10.1128/IAI.01681-14
9. Bergstrom, K. S., Kissoon-Singh, V., Gibson, D. L., Ma, C., Montero, M., Sham, H. P., et al. (2010). Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 6:e1000902. doi: 10.1371/journal.ppat.1000902
10. Boutaga, K., van Winkelhoff, A. J., Vandenbroucke-Grauls, C. M., and Savelkoul, P. H. (2005). Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. FEMS Immunol. Med. Microbiol. 45, 191-199. doi: 10.1016/j.femsim.2005.03.011
11. Corthesy, B. (2013). Role of secretory IgA in infection and maintenance of homeostasis. Autoimmun. Rev. 12, 661-665. doi: 10.1016/j.autrev.2012.10.012
12. Corthesy, B., and Spertini, F. (1999). Secretory immunoglobulin A: from mucosal protection to vaccine development. Biol. Chem. 380, 1251-1262. doi: 10.1515/BC.1999.160
13. Dethlefsen, L., and Relman, D. A. (2011). Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4554-4561. doi: 10.1073/pnas.1000087107
14. Dicksved, J., Schreiber, O., Willing, B., Petersson, J., Rang, S., Phillipson, M., et al. (2012). Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction. PLoS ONE 7:e46399. doi: 10.1371/journal.pone.0046399
15. Eeckhaut, V., Machiels, K., Perrier, C., Romero, C., Maes, S., Flahou, B., et al. (2013). Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62, 1745-1752. doi: 10.1136/gutjnl-2012-303611
16. Furet, J. P., Quénée, P., and Tailliez, P. (2004). Molecular quantification of lactic acid bacteria in fermented milk products using real-time quantitative PCR. Inter. J. Food. Microbiol. 97, 197-207. doi: 10.1016/j.ijfoodmicro.2004.04.020
17. Gonzalez-Rey, E., Varela, N., Sheibanie, A. F., Chorny, A., Ganea, D., and Delgado, M. (2006). Cortistatin, an anti-inflammatory peptide with therapeutic action in inflammatory bowel disease. Proc. Natl. Acad. Sci. U.S.A. 103, 4228-4233. doi: 10.1073/pnas.0508997103
18. Grasa, L., Abecia, L., Castro, M., de Jalón, J. A., Latorre, E., Alcalde, A. I., et al. (2015). Antibiotic-induced depletion of murine microbiota induces mild inflammation and changes in Toll-like receptor patterns and intestinal motility. Microb. Ecol. doi: 10.1007/s00248-015-0613-8. [Epub ahead of print].
19. Hasnain, S. Z., Thornton, D. J., and Grencis, R. K. (2011). Changes in the mucosal barrier during acute and chronic Trichuris muris infection. Parasite Immunol. 33, 45-55. doi: 10.1111/j.1365-3024.2010.01258.x
20. Hawrelak, J. A., and Myers, S. P. (2004). The causes of intestinal dysbiosis: a review. Altern. Med. Rev. 9, 180-197.
21. Heilig, H. G. H. J., Zoetendal, E. G., Vaughan, E. E., Marteau, P., Akkermans, A. D. L., and de Vos, W. M. (2002). Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined bu specific amiplication of 16S ribosomal DNA. Appl. Environ. Microbiol. 68, 114-123. doi: 10.1128/AEM.68.1.114-123.2002
22. Hooper, L. V., Littman, D. R., and Macpherson, A. J. (2012). Interactions between the microbiota and the immune system. Science 336, 1268-1273. doi: 10.1126/science.1223490
23. Huijsdens, X. W., Linskens, R. K., Mak, M., Meuwissen, S. G. M., Vandenbrouche-Grauls, C. M. J. E., and Savelkoul, P. H. M. (2002). Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J. Clin. Microbiol. 40, 4423-4427. doi: 10.1128/JCM.40.12.4423-4427.2002
24. Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., et al. (2011). Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60, 631-637. doi: 10.1136/gut.2010.223263
25. Kao, D., Hotte, N., Gillevet, P., and Madsen, K. (2014). Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile. J. Clin. Gastroenterol. 48, 625-628. doi: 10.1097/MCG.0000000000000131
26. Konig, J., and Brummer, R. J. (2014). Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Benef. Microbes. 4995, 247-261. doi: 10.3920/BM2013.0033
27. Krisanaprakornkit, S., Kimball, J. R., Weinberg, A., Darveau, R. P., Bainbridge, B. W., and Dale, B. A. (2000). Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 68, 2907-2915. doi: 10.1128/IAI.68.5.2907-2915.2000
28. Kump, P. K., Grochenig, H. P., Lackner, S., Trajanoski, S., Reicht, G., Hoffmann, K. M., et al. (2013). Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm. Bowel. Dis. 19, 2155-2165. doi: 10.1097/MIB.0b013e31829ea325
29. Kunde, S., Pham, A., Bonczyk, S., Crumb, T., Duba, M., Conrad, H., et al. (2013). Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 56, 597-601. doi: 10.1097/MPG.0b013e318292fa0d
30. Lawley, T. D., Clare, S., Walker, A. W., Stabler, R. A., Croucher, N., Mastroeni, P., et al. (2009). Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect. Immun. 77, 3661-3669. doi: 10.1128/IAI.00558-09
31. Lawley, T. D., Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C., et al. (2012). Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8:e1002995. doi: 10.1371/journal.ppat.1002995
32. Lee, I. H., Dinudom, A., Sanchez-Perez, A., Kumar, S., and Cook, D. I. (2007). Akt mediates the effect of insulin on epithelial sodium channels by inhibiting Nedd4-2. J. Biol. Chem. 282, 29866-29873. doi: 10.1074/jbc.M701923200
33. Lim, M. X., Png, C. W., Tay, C. Y., Teo, J. D., Jiao, H., Lehming, N., et al. (2014). Differential regulation of proinflammatory cytokine expression by MAP kinases in macrophages in response to intestinal parasite infection. Infect. Immun. 82, 4789-4801. doi: 10.1128/IAI.02279-14
34. Linden, S. K., Florin, T. H., and McGuckin, M. A. (2008). Mucin dynamics in intestinal bacterial infection. PLoS ONE 3:e3952. doi: 10.1371/journal.pone.0003952
35. Ludwig, W., and Schleifer, K. H. (2000). How quantitative is quantitative PCR with respect to cell counts?. Syst. Appl. Microbiol. 23, 556-562. doi: 10.1016/S0723-2020(00)80030-2
36. Lutgendorff, F., Akkermans, L. M., and Soderholm, J. D. (2008). The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr. Mol. Med. 8, 282-298. doi: 10.2174/156652408784533779
37. Macfarlane, S., Woodmansey, E. J., and Macfarlane, G. T. (2005). Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl. Environ. Microbiol. 71, 7483-7492. doi: 10.1128/AEM.71.11.7483-7492.2005
38. Matsuda, K., Tsuji, H., Asahara, T., Kado, Y., and Nomoto, K. (2007). Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl. Environ. Microbiol. 73, 32-39. doi: 10.1128/AEM.01224-06
39. Maynard, C. L., Elson, C. O., Hatton, R. D., and Weaver, C. T. (2012). Reciprocal interactions of the intestinal microbiota and immune system. Nature 489, 231-241. doi: 10.1038/nature11551
40. Mitsuoka, T. (1978). Intestinal Bacteria and Health: An Introductory Narrative. Tokyo: Harcourt Brace Jovanovich Japan.
41. Petrof, E. O., and Khoruts, A. (2014). From stool transplantation to next-generation microbiota therapeutics. Gastroenterology 146, 1573-1582. doi: 10.1053/j.gastro.2014.01.004
42. Rekha, R., Rizvi, M. A., and Jaishree, P. (2006). Designing and validation of genus-specific primers for human gut flora study. Electron. J. Biotechn. 9, 505-511. doi: 10.2225/vol9-issue5-fulltext-2
43. Rinttila, T., Kassinen, A., Malinen, E., Krogius, L., and Palva, A. (2004). Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J. Appl. Microbiol. 97, 1166-1177. doi: 10.1111/j.1365-2672.2004.02409.x
44. Rudney, J. D., Pan, Y., and Chen, P. (2003). Streptococcal diversity in oral biofilms with respect to salivary function. Arch. Oral. Biol. 48, 475-493. doi: 10.1016/S0003-9969(03)00043-8
45. Scarpa, M., Grillo, A., Brun, P., Castoro, C., Pozza, A., Cavallo, D., et al. (2012). Innate immune environment in ileal pouch mucosa: alpha5 defensin up-regulation as predictor of chronic/relapsing pouchitis. J. Gastrointest. Surg. 16, 188-201. doi: 10.1007/s11605-011-1720-6
46. Semple, F., and Dorin, J. R. (2012). beta-Defensins: multifunctional modulators of infection, inflammation and more?. J. Innate. Immun. 4, 337-348. doi: 10.1159/000336619
47. Shanahan, F., and Quigley, E. M. (2014). Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. Gastroenterology 146, 1554-1563. doi: 10.1053/j.gastro.2014.01.050
48. Smits, L. P., Bouter, K. E., deVos, W. M., Borody, T. J., and Nieuwdorp, M. (2013). Therapeutic potential of fecal microbiota transplantation. Gastroenterolgy 145, 946-953. doi: 10.1053/j.gastro.2013.08.058
49. Strowski, M. Z., and Wiedenmann, B. (2009). Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases. Gut 58, 1044-1045. doi: 10.1136/gut.2009.179325
50. Turner, J. R. (2009). Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799-809. doi: 10.1038/nri2653
51. Udayappan, S. D., Hartstra, A. V., Dallinga-Thie, G. M., and Nieuwdorp, M. (2014). Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus. Clin. Exp. Immunol. 177, 24-29. doi: 10.1111/cei.12293
52. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., et al. (2013). Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407-415. doi: 10.1056/NEJMoa1205037
53. Vermeire, S., Joossens, M., Verbeke, K., and Hildebrand, F. (2012). A pilot study on the safety and efficacy of faecal microbiota transplantation in refractory Crohn's disease. Gastroenterology 142(5 Suppl. 1), S-360. doi: 10.1016/S0016-5085(12)61356-0
54. Walter, J., Hertel, C., Tannock, G. W., Lis, C. M., Munro, K., and Hammes, W. P. (2001). Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 67, 2578-2585. doi: 10.1128/AEM.67.6.2578-2585.2001
55. Wang, H., Zhang, W., Zuo, L., Dong, J., Zhu, W., Li, Y., et al. (2014). Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocation. Lett. Appl. Microbiol. 58, 384-392. doi: 10.1111/lam.12201
56. Wang, Q., Fang, C. H., and Hasselgren, P. O. (2001). Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1013-R1023.
57. Wehkamp, J., Fellermann, K., Herrlinger, K. R., Bevins, C. L., and Stange, E. F. (2005). Mechanisms of disease: defensins in gastrointestinal diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 406-415. doi: 10.1038/ncpgasthep0265
58. Wenzel, U. A., Maqnusson, M. K., Rydstrom, A., Jonstrand, C., Hengst, J., Johansson, M. E., et al. (2014). Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis. PLoS ONE 9:e100217. doi: 10.1371/journal.pone.0100217
59. Wlodarska, M., Willing, B., Keeney, K. M., Menendez, A., Bergstrom, K. S., Gill, N., et al. (2011). Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79, 1536-1545. doi: 10.1128/IAI.01104-10